Sorafenib in combination with capecitabine: An oral regimen for patients with HER2-negative locally advanced or metastatic breast cancer

1. Baselga, J.
2. Segalla, J.G.M.
3. Roché, H.
4. Del Giglio, A.
5. Pinczowski, H.
6. Ciruelos, E.M.
7. Cabral Filho, S.
8. Gómez, P.
9. Van Eyll, B.
10. Bermejo, B.
11. Llombart, A.
12. Garicochea, B.
13. Durán, M.A.C.
14. Hoff, P.M.G.
15. Espié, M.
16. Gemeinder De Moraes Jr., A.A.
17. Ribeiro, R.A.
18. Mathias, C.
19. Gil, M.G.
20. Ojeda, B.
21. Morales, J.
22. Ro, S.K.
23. Li, S.
24. Costa, F.